Drug use and opioid substitution treatment for prisoners

被引:51
|
作者
Stoever, Heino [1 ]
Michels, Ingo Ilja [2 ]
机构
[1] Univ Appl Sci, Res Inst Addict, D-60318 Frankfurt, Germany
[2] Deutsch Gesell Tech Zusammenarbeit GTZ, Cent Asia Drug Act Programme CADAP European Union, Bishkek, Kyrgyzstan
关键词
METHADONE-MAINTENANCE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C; BUPRENORPHINE; TRANSMISSION; RISK; HIV; ATTITUDES; INJECTION;
D O I
10.1186/1477-7517-7-17
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Drug use is prevalent throughout prison populations, and, despite advances in drug treatment programmes for inmates, access to and the quality of these programmes remain substantially poorer than those available for non-incarcerated drug users. Because prisoners may be at greater risk for some of the harms associated with drug use, they deserve therapeutic modalities and attitudes that are at least equal to those available for drug users outside prison. This article discusses drug use by inmates and its associated harms. In addition, this article provides a survey of studies conducted in prisons of opioid substitution therapy (OST), a clinically effective and cost-effective drug treatment strategy. The findings from this overview indicate why treatment efforts for drug users in prison are often poorer than those available for drug users in the non-prison community and demonstrate how the implementation of OST programmes benefits not only prisoners but also prison staff and the community at large. Finally, the article outlines strategies that have been found effective for implementing OST in prisons and offers suggestions for applying these strategies more broadly.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Factors influencing pharmacy services in opioid substitution treatment
    Chaar, Betty B.
    Wang, Holly
    Day, Carolyn A.
    Hanrahan, Jane R.
    Winstock, Adam R.
    Fois, Romano
    DRUG AND ALCOHOL REVIEW, 2013, 32 (04) : 426 - 434
  • [22] Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
    Kenworthy, James
    Yi, Yunni
    Wright, Antony
    Brown, Jim
    Madrigal, Ana Maria
    Dunlop, William C. N.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 740 - 748
  • [23] Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective
    Hall, Natasha Yvonne
    Le, Long
    Majmudar, Ishani
    Mihalopoulos, Cathrine
    DRUG AND ALCOHOL DEPENDENCE, 2021, 221
  • [24] Factors Related to Injection Drug Use Among Female Prisoners
    Jackson, Dorothy Octavia
    Cropsey, Karen L.
    Weaver, Michael F.
    Villalobos, Gabriella C.
    Eldridge, Gloria
    Stitzer, Maxine L.
    SUBSTANCE USE & MISUSE, 2010, 45 (03) : 368 - 383
  • [25] Diversion of Methadone and Buprenorphine from Opioid Substitution Treatment: The Importance of Patients' Attitudes and Norms
    Johnson, Bjorn
    Richert, Torkel
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2015, 54 : 50 - 55
  • [26] Changes in opioid-related deaths following increased access to opioid substitution treatment
    Andersson, Lisa
    Hakansson, Anders
    Berge, Jonas
    Johnson, Bjorn
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [27] Sexual health services in community pharmacy for women on opioid substitution treatment: a qualitative study
    Medina-Perucha, Laura
    Scott, Jenny
    Chapman, Sarah
    Barnett, Julie
    Dack, Charlotte
    Family, Hannah
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30 (04): : 733 - 738
  • [28] Multiple burdens of stigma for prisoners participating in opioid antagonist treatment (OAT) programmes in Indonesian prisons: a qualitative study
    Komalasari, Rita
    Wilson, Sarah
    Nasir, Sudirman
    Haw, Sally
    INTERNATIONAL JOURNAL OF PRISONER HEALTH, 2021, 17 (02) : 156 - 170
  • [29] Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy
    Wang, Chih-Wen
    Chuang, Hung-Yi
    Chiang, Hung-Che
    Huang, Po-Chin
    Yu, Ming-Lung
    Dai, Chia-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 454 - 460
  • [30] Contingency Management in Opioid Substitution Treatment
    Specka, M.
    Boening, A.
    Scherbaum, N.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (07) : 395 - 403